{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:49:26Z","timestamp":1791560966980,"version":"4.3.4"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:p>\n                    Primary vaginal leiomyosarcoma is a rare malignancy characterized by similar histologic features as uterine leiomyosarcomas. Previous studies of uterine leiomyosarcomas have shown specific molecular alterations, including frequent alterations in\n                    <jats:italic toggle=\"yes\">TP53, RB1, ATRX, PTEN, MED12, CDKN2A<\/jats:italic>\n                    , and\n                    <jats:italic toggle=\"yes\">MDM2<\/jats:italic>\n                    . Similar alterations have been found in primary vaginal leiomyosarcomas as well as an alternative tumorigenic pathway associated with HPV. Herein, we describe a primary vaginal leiomyosarcoma in a 46-yr-old patient. The tumor was located in the vaginal wall without involvement of the uterus or cervix. Morphologically, it was composed of atypical, spindled cells, with a mitotic rate of 25 mitotic figures per 10 high-power fields and tumor type necrosis. Immunohistochemistry showed positivity for h-caldesmon, SMA, desmin, and ER, along with p53 null pattern expression and loss of ATRX and Rb. Next-generation sequencing analysis revealed mutations in\n                    <jats:italic toggle=\"yes\">ATRX<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">PTEN<\/jats:italic>\n                    , along with homozygous deletions of\n                    <jats:italic toggle=\"yes\">RB1<\/jats:italic>\n                    , and deep deletions in\n                    <jats:italic toggle=\"yes\">TP53<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">NCOR1<\/jats:italic>\n                    tumor suppressor genes. High-risk human papillomavirus (HR-HPV) E6\/E7 mRNA in situ hybridization was performed and showed no staining.\n                  <\/jats:p>","DOI":"10.1097\/pgp.0000000000001149","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T23:00:07Z","timestamp":1765839607000},"page":"499-503","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Molecular and Immunohistochemical Characteristics of Primary Vaginal Leiomyosarcoma: Case Report and Review of the Literature"],"prefix":"10.1097","volume":"45","author":[{"given":"Chantal","family":"Durgana","sequence":"first","affiliation":[{"name":"School of Medicine, University of California, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Grenert","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of California, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Gasper","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of California, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"R1-20261009","doi-asserted-by":"crossref","first-page":"e1005850","DOI":"10.1371\/journal.pgen.1005850","article-title":"Exome sequencing of uterine leiomyosarcomas identifies frequent mutations in TP53, ATRX, and MED12","volume":"12","author":"M\u00e4kinen","year":"2016","journal-title":"PLoS Genet"},{"key":"R2-20261009","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1002\/cncr.33542","article-title":"Relationships between highly recurrent tumor suppressor alterations in 489 leiomyosarcomas","volume":"127","author":"Schaefer","year":"2021","journal-title":"Cancer"},{"key":"R3-20261009","first-page":"2072","article-title":"Targeted next-generation sequencing of cancer genes identified frequent TP53 and ATRX mutations in leiomyosarcoma","volume":"7","author":"Yang","year":"2015","journal-title":"Am J Transl Res"},{"key":"R4-20261009","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/PAS.0000000000001862","article-title":"HPV51-associated leiomyosarcoma: a novel class of TP53\/RB1-wildtype tumor with predilection for the female lower reproductive tract","volume":"46","author":"Williams","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"R5-20261009","doi-asserted-by":"crossref","first-page":"105713","DOI":"10.1016\/j.humpath.2024.105713","article-title":"Vulvar and vaginal leiomyosarcomas: Immunohistochemical, molecular genetic and MDM2 fluorescence in situ hybridization analysis of three cases","volume":"155","author":"Dashti","year":"2025","journal-title":"Hum Pathol"},{"key":"R6-20261009","doi-asserted-by":"crossref","first-page":"100084","DOI":"10.1016\/j.modpat.2022.100084","article-title":"Molecular-based immunohistochemical algorithm for uterine leiomyosarcoma diagnosis","volume":"36","author":"Momeni-Boroujeni","year":"2023","journal-title":"Mod Pathol"},{"key":"R7-20261009","first-page":"689","article-title":"Smooth muscle tumors of the vagina","volume":"53","author":"Tavassoli","year":"1979","journal-title":"Obstet Gynecol"},{"key":"R8-20261009","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/PAS.0000000000000920","article-title":"Criteria for risk stratification of vulvar and vaginal smooth muscle tumors: an evaluation of 71 cases comparing proposed classification systems","volume":"42","author":"Sayeed","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R10-20261009","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/his.15420","article-title":"Challenges of a tailored immunohistochemistry algorithm for uterine leiomyosarcoma: an integrated analysis of leiomyomas with bizarre nuclei and fumarate hydratase (FH) deficiency","volume":"86","author":"Alves-Vale","year":"2025","journal-title":"Histopathology"},{"key":"R11-20261009","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/PGP.0000000000001101","article-title":"The morphologic and molecular heterogeneity of fumarate hydratase-deficient leiomyomas: integrative molecular profiling of uterine smooth muscle tumors with histologic feature correlation","volume":"44","author":"Szczepanski","year":"2025","journal-title":"Int J Gynecol Pathol"},{"key":"R12-20261009","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/modpathol.2017.56","article-title":"Leiomyoma with bizarre nuclei: a morphological, immunohistochemical and molecular analysis of 31 cases","volume":"30","author":"Bennett","year":"2017","journal-title":"Mod Pathol"},{"key":"R13-20261009","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1158\/1078-0432.CCR-24-0148","article-title":"Developing novel genomic risk stratification models in soft tissue and uterine leiomyosarcoma","volume":"30","author":"Dermawan","year":"2024","journal-title":"Clin Cancer Res"},{"key":"R14-20261009","doi-asserted-by":"crossref","first-page":"938","DOI":"10.3390\/cancers16050938","article-title":"The future of targeted therapy for leiomyosarcoma","volume":"16","author":"Denu","year":"2024","journal-title":"Cancers (Basel)"},{"key":"R15-20261009","doi-asserted-by":"crossref","first-page":"630773","DOI":"10.3389\/fimmu.2021.630773","article-title":"Effect of NCOR1 mutations on immune microenvironment and efficacy of immune checkpoint inhibitors in patient with bladder cancer","volume":"12","author":"Lin","year":"2021","journal-title":"Front Immunol"},{"key":"R16-20261009","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.annonc.2022.05.519","article-title":"Pembrolizumab in microsatellite instability high or mismatch repair deficient cancers: updated analysis from the phase II KEYNOTE-158 study","volume":"33","author":"Maio","year":"2022","journal-title":"Ann Oncol"},{"key":"R17-20261009","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S1470-2045(20)30445-9","article-title":"Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study","volume":"21","author":"Marabelle","year":"2020","journal-title":"Lancet Oncol"},{"key":"R18-20261009","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1365-2559.2007.02699.x","article-title":"Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential","volume":"50","author":"O\u2019Neill","year":"2007","journal-title":"Histopathology"},{"key":"R19-20261009","doi-asserted-by":"crossref","first-page":"103955","DOI":"10.1016\/j.critrevonc.2023.103955","article-title":"The biology and treatment of leiomyosarcomas","volume":"184","author":"Kerrison","year":"2023","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PGP.0000000000001149","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:00:48Z","timestamp":1791558048000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/PGP.0000000000001149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000001149","relation":{},"ISSN":["0277-1691","1538-7151"],"issn-type":[{"value":"0277-1691","type":"print"},{"value":"1538-7151","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"2025-07-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}